Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19322756 | 1.00 | OPRM1 (0.41) | OPRM1OPRD1OPRK1CTDSP1 | |
| SCHEMBL17552962 | 1.00 | OPRM1 (0.41) | OPRM1OPRD1OPRK1CTDSP1 | |
| SCHEMBL11888558 | 0.90 | OPRM1 (0.43) | OPRM1OPRD1OPRK1CTDSP1 | |
| SCHEMBL17552919 | 0.87 | OPRM1 (0.43) | OPRM1OPRD1OPRK1 | |
| SCHEMBL16131233 | 0.87 | OPRM1 (0.43) | OPRM1OPRD1OPRK1 | |
| SCHEMBL19322800 | 0.81 | OPRM1 (0.41) | OPRM1OPRD1OPRK1CTDSP1 | |
| SCHEMBL12091293 | 0.79 | OPRM1 (0.43) | OPRM1OPRD1OPRK1 | |
| SCHEMBL19322786 | 0.78 | OPRM1 (0.42) | OPRM1OPRD1OPRK1CTDSP1 | |
| SCHEMBL19322755 | 0.78 | OPRM1 (0.40) | OPRM1OPRD1OPRK1CTDSP1 | |
| SCHEMBL19322762 | 0.78 | OPRM1 (0.53) | OPRM1OPRD1OPRK1CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170253604-A9 | PROCESS FOR IMPROVED OXYMORPHONE SYNTHESIS | RHODES TECHNOLOGIES (US) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253604-A9 | PROCESS FOR IMPROVED OXYMORPHONE SYNTHESIS | OPRK1, OGFR, OPRD1 | OPRM1 4/4885OPRD1 3/4885OPRK1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.